Company Profile
Pfizer the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- drugs (72.8%): for treating cardio-vascular diseases, nervous system disorders, infectious and respiratory diseases, urological disorders, ophthalmological diseases; etc.;
- vaccines, oncology products and consumer goods (26.2%);
- other (1%).
Net sales are distributed geographically as follows: the United States (44.4%), Europe (20%) and other (35.6%).
- drugs (72.8%): for treating cardio-vascular diseases, nervous system disorders, infectious and respiratory diseases, urological disorders, ophthalmological diseases; etc.;
- vaccines, oncology products and consumer goods (26.2%);
- other (1%).
Net sales are distributed geographically as follows: the United States (44.4%), Europe (20%) and other (35.6%).
Source: Cofisem - Last Update: 2016-09-27
Key Executives
| Chairman and Chief Executive Officer | |
| General Secretary | |
| Chief Financial Officer | |
| Director for Research and Development |
Source: Cofisem - Last Update: 2016-08-04
Key Figures
| Millenium | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Net sales | 44,713,236 | 45,403,372 | 47,214,748 | 53,989,784 | 61,713,988 |
| Cost of sales | 8,830,798 | 8,765,812 | 8,774,049 | 10,373,991 | 13,807,274 |
| Payroll | |||||
| Operating income | 10,823,402 | 12,126,787 | 15,310,194 | 11,056,803 | 11,681,037 |
| Taxes | 1,821,443 | 2,855,730 | 3,941,274 | 2,344,994 | 3,682,245 |
| Net income | 6,394,273 | 8,391,455 | 20,202,464 | 13,361,524 | 9,199,663 |
| Group net income | 6,370,476 | 8,362,165 | 20,139,308 | 13,335,896 | 9,161,220 |
| Fiscal year end | 12.15 | 12.14 | 12.13 | 12.12 | 12.11 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards |
Source: Cofisem - Last Update: 2016-09-27
Shareholder information
| Vanguard Group | |
| State Street Corporation | |
| BlackRock Fund Advisors | |
| T. Rowe Price Associates | |
| Capital World Investors | |
| Wellington Management Company | |
| Northern Trust Investments | |
| Goldman, Sachs & Co. | |
| J.P. Morgan Investment Management | |
| State Street Global Advisors (Aus) |
Source: Cofisem - Last Update: 2016-08-04
Address
Pfizer
235 street East 42nd
US-NY 10017-5755 New York City, New York
United States
Phone number: +1 212 573 2323
Fax: +1 212 573 7851
http://www.pfizer.com
Source: Cofisem - Last Update: 2016-09-27
Please contact MyQuestion.Italy@euronext.com for Company Profile support.